Your session is about to expire
← Back to Search
Antiretroviral Therapy for HIV
Study Summary
This trial will test the safety and effectiveness of a new HIV treatment regimen.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Find a Location
Who is running the clinical trial?
Media Library
- I have not used at least one of the specified HIV drugs before.My HIV viral load is between 400 and 20,000 copies/ml.I am HIV-positive.My HIV treatment failed twice with viral loads between 400 and 20,000.My HIV treatment initially worked, lowering my viral load below 400 in two tests.My HIV treatment failed twice with viral loads between 400 and 20,000.I have not used at least one of the specific HIV medications before.I am 18 years old or older.I have been on HIV treatment including indinavir or nelfinavir for at least 16 weeks.I have been on HIV medication including indinavir or nelfinavir for over 16 weeks.My CD4 cell count is 50 or higher.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
At how many different hospitals is this clinical trial being conducted?
"There are 40 clinical trial sites for this medication, which can be found in locations such as Stony Brook, Los Angeles and Mt. Vernon among other places. To limit travel if you enroll, it is best to choose the location nearest you."
Is this clinical trial only testing on individuals below a certain age?
"In order to be eligible for this study, potential participants must between 18 and 0 years old. There are currently 110 trials for people under the age of 18 and 367 for those over 65."
Has this particular medication been cleared by the FDA?
"While there is some evidence of this treatment's safety, it remains unproven whether or not it is effective. Our team rates its safety as a 2."
Does this clinical trial have any prerequisites for participants?
"100 individuals infected with HIV that meet the following conditions are eligible for this study: being 18 years or older, having used antiretroviral treatment including indinavir or nelfinavir for a minimum of 16 weeks, and being unexposed to one of the selected NRTIs."
Who else is applying?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger